Dr. Karie Runcie
Claim this profileColumbia University
Studies Prostate Cancer
Studies Renal Cell Carcinoma
7 reported clinical trials
15 drugs studied
Area of expertise
1Prostate Cancer
Stage I
Stage II
BRCA1 positive
2Renal Cell Carcinoma
Stage IV
HBsAg negative
HBV DNA negative
Affiliated Hospitals
Clinical Trials Karie Runcie is currently running
Combination Immunotherapy
for Kidney Cancer
This trial is testing two new drugs, botensilimab and balstilimab, in patients with advanced kidney cancer who haven't been treated before. The new drugs aim to help the immune system better recognize and attack cancer cells. The study will compare these treatments over several months.
Recruiting1 award Phase 212 criteria
Canakinumab + Spartalizumab
for Renal Cell Carcinoma
Primary Objective: * To confirm the safety and feasibility of canakinumab and spartalizumab (PDR-001) administered using a standard dose / schedule in the neo-adjuvant setting in renal cell carcinoma Secondary Objectives: * To assess the immune response to combination canakinumab and spartalizumab * To assess anti-tumor activity as measured by pathologic downstaging
Recruiting1 award Phase < 111 criteria
More about Karie Runcie
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Karie Runcie has experience with
- Ipilimumab
- Nivolumab
- Canakinumab
- Spartalizumab
- BMS-986218
- Degarelix
Breakdown of trials Karie Runcie has run
Prostate Cancer
Renal Cell Carcinoma
Cancer
Colorectal Cancer
Lynch Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karie Runcie specialize in?
Karie Runcie focuses on Prostate Cancer and Renal Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage I patients, or patients who are Stage II.
Is Karie Runcie currently recruiting for clinical trials?
Yes, Karie Runcie is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Karie Runcie has studied deeply?
Yes, Karie Runcie has studied treatments such as Ipilimumab, Nivolumab, Canakinumab.
What is the best way to schedule an appointment with Karie Runcie?
Apply for one of the trials that Karie Runcie is conducting.
What is the office address of Karie Runcie?
The office of Karie Runcie is located at: Columbia University, New York, New York 10032 United States. This is the address for their practice at the Columbia University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.